Locate Bio's LDGraft Granted FDA Breakthrough Device Designa

LDGraft is a next-generation bone graft substitute for spinal fusion, with uniquely encapsulated rhBMP-2 for controlled and extended-release Seeking to target significant and growing chronic low

Related Keywords

, Gewinn Nur , Tim Stamper , Ciara Martin , University Of Nottingham , Breakthrough Device Program , World Health Organisation , Mercia Asset Management , Drug Administration , United Kingdom Based , Breakthrough Device , Device Program , Locate Bio , Graft Substitutes Market Insights , Elocate , Dgraft , Granted , Breakthrough , Device , Resignation ,